Clinical Trial Update: The Efficacy of Open Label Infliximab for the Induction and Maintenance of Mucosal Healing in Small Bowel Crohn's Disease Assessed Through Wireless Camera Endoscopy [Phase 4]

View source ↗

Summary

A Phase 4 open-label trial evaluated infliximab for induction and maintenance of mucosal healing in small bowel Crohn's disease using wireless capsule endoscopy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Remicade (infliximab)

Snippet

Sponsor: Janssen Inc. | Conditions: Crohn's Disease | Phase 4 | Status: COMPLETED